Full Description
This book provides cutting-edge information on the epidemiology, etiology and pathophysiology of several prevalent occupational and environmental skin diseases (OSD/ESD), with a particular focus on skin health safety issues, risk factors, preventive measures and recent advances in the management of these diseases. It also highlights recent discoveries and developments concerning novel therapeutic agents for inflammatory OSD, especially findings that are supported by clinical data and have the potential to transform conventional prophylactic and therapeutic approaches. For example, despite their increasing prevalence, the management of allergic skin diseases is sometimes challenging, mainly due to limited treatment choices. In several countries, steroids are the only treatment used. However, in cases of contraindications, adverse effects or unsatisfactory steroidal therapies, alternative treatments are indispensable. As such, an understanding of promising anti-allergic agents enhances allergy research and could eventually lead to novel alternative therapeutic and adjuvant remedies, which are of the utmost importance. This book offers a valuable resource for researchers, graduate students and practitioners in the field of public health in general, especially those working in environmental and occupational medicine, as well as physicians.
Contents
Chapter 1 Introduction.- PART I: SKIN IRRITANTS, SENSITIZERS AND CARCINOGENS.- Chapter 2 Skin Function and Occupational Cutaneous Hazards.- PART II ENVIRONMENTAL AND OCCUPATIONAL ECZEMATOUS SKIN DISORDERS.- Chapter 3 Atopic dermatitis.- Chapter 4 Occupational Contact.- Chapter 5 Quality of Work Environment and Frequency of Work-related Dermatitis in Dust-exposed African Informal Coltan Miners.- Chapter 6 Occupational Cement Dermatitis and Cement.- Chapter 7 Alternative Therapies for Eczematous Environmental and Occupational Skin Diseases and their anti-inflammatory mechanisms.- Chapter 8 Sacran: Novel Natural Sulfated Polysaccharide as Antiallergic Skincare Biomaterial for Atopic Dermatitis.- Chapter 9 Experimental Anti-Allergic and Immunomodulatory Effects of Vernonia amygdalina-derived Vernodalin and Plant Extracts.- Chapter 10 Clinical Anti-Allergic Effects of Vernonia amygdalina Leaf Extracts.- PART III FUNGAL, NEGLECTED SEASONAL, EPIDEMIC AND OTHER ENVIRONMENTAL KIN DISORDERS.- Chapter 11 Common Environmental Dermatomycoses.- Chapter 12 Sarcoptic Skin Disease (Scabies).- Chapter 13 Frequency and Clinical Features of Sarcoptic Skin Disease in.- Congolese Schoolchildren.- Chapter 14 Paederus Dermatitis: Environmental Risk Factors, Clinical Features and Management.- Chapter 15 Overview on other Environmental Skin Disorders.
